Literature DB >> 19326703

Is leishmaniasis in Sri Lanka benign and be ignored?

N D Karunaweera1, U S Rajapaksa.   

Abstract

Cutaneous leishmaniasis is now an endemic disease in Sri Lanka. Many studies have focussed on various aspects of this disease but the knowledge, particularly on epidemiological and vector aspects is still poor and the awareness among the general public and even medical/paramedical personnel regarding this disease remains grossly inadequate. The steady increase in the numbers and spread of cutaneous leishmaniasis cases in Sri Lanka and the very close similarity (genotypic and phenotypic) between the local parasite Leishmania donovani MON-37 and the parasite causing visceral leishmaniasis in India (L. donovani MON-2), considered together with the more recent case reports of autochthonous cases of visceral disease in this country, calls for urgent action for setting up of a surveillance programme to estimate the true disease burden and to implement an organized control strategy, combined with operational and epidemiological research to aid control efforts to avert a potentially major catastrophe of more virulent form of leishmaniasis, particularly the visceral type becoming endemic in Sri Lanka.

Entities:  

Mesh:

Year:  2009        PMID: 19326703

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  6 in total

1.  In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani.

Authors:  N H Manamperi; S Oghumu; N Pathirana; M V C de Silva; W Abeyewickreme; A R Satoskar; N D Karunaweera
Journal:  Parasite Immunol       Date:  2017-03       Impact factor: 2.280

Review 2.  Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application.

Authors:  Om Prakash Singh; Mallikarjuna Rao Gedda; Shyam Lal Mudavath; Onkar Nath Srivastava; Shyam Sundar
Journal:  Nanomedicine (Lond)       Date:  2019-07-17       Impact factor: 5.307

3.  Cross-sectional study to assess risk factors for leishmaniasis in an endemic region in Sri Lanka.

Authors:  Shalindra Ranasinghe; Rajitha Wickremasinghe; Asoka Munasinghe; Sanjeeva Hulangamuwa; Sundaramoorthy Sivanantharajah; Kamal Seneviratne; Samantha Bandara; Indira Athauda; Chaturi Navaratne; Ositha Silva; Hasini Wackwella; Greg Matlashewski; Renu Wickremasinghe
Journal:  Am J Trop Med Hyg       Date:  2013-08-05       Impact factor: 2.345

4.  Leishmania donovani zymodeme MON-37 isolated from an autochthonous visceral leishmaniasis patient in Sri Lanka.

Authors:  Shalindra Ranasinghe; Wen-Wei Zhang; Renu Wickremasinghe; Priyanka Abeygunasekera; Vishvanath Chandrasekharan; Sunethra Athauda; Suresh Mendis; Sanjeeva Hulangamuwa; Greg Matlashewski; Francine Pratlong
Journal:  Pathog Glob Health       Date:  2012-11       Impact factor: 2.894

5.  Tissue Impression Smears as a Supplementary Diagnostic Method for Histopathology in Cutaneous Leishmaniasis in Sri Lanka.

Authors:  Nuwani H Manamperi; M V Chandu de Silva; Nishantha Pathirana; Wimal Abeyewickreme; Nadira D Karunaweera
Journal:  Am J Trop Med Hyg       Date:  2018-01-11       Impact factor: 2.345

6.  Characterisation of cutaneous leishmaniasis in Matara district, southern Sri Lanka: evidence for case clustering.

Authors:  K K G D U L Kariyawasam; C S Edirisuriya; U Senerath; D Hensmen; H V Y D Siriwardana; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.